Norinchukin Bank The grew its position in shares of Aetna Inc. (NYSE:AET) by 57.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 36,241 shares of the company’s stock after purchasing an additional 13,223 shares during the quarter. Norinchukin Bank The’s holdings in Aetna were worth $5,763,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. State of Tennessee Treasury Department increased its position in shares of Aetna by 26.3% during the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock valued at $84,692,000 after purchasing an additional 116,280 shares during the last quarter. Banque Pictet & Cie SA purchased a new position in shares of Aetna in the 2nd quarter valued at approximately $10,567,000. Pictet & Cie Europe SA purchased a new position in shares of Aetna in the 2nd quarter valued at approximately $2,269,000. NBT Bank N A NY purchased a new position in shares of Aetna in the 2nd quarter valued at approximately $215,000. Finally, Eaton Vance Management lifted its stake in shares of Aetna by 18.3% in the 2nd quarter. Eaton Vance Management now owns 1,050,685 shares of the company’s stock valued at $159,526,000 after purchasing an additional 162,502 shares during the period. Hedge funds and other institutional investors own 88.41% of the company’s stock.
A number of research firms have recently commented on AET. Jefferies Group LLC restated a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Credit Suisse Group started coverage on Aetna in a report on Thursday, November 2nd. They issued a “neutral” rating and a $174.00 target price for the company. Zacks Investment Research lowered Aetna from a “buy” rating to a “hold” rating in a report on Monday, October 16th. Cantor Fitzgerald reissued an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Finally, Raymond James Financial, Inc. raised Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 target price for the company in a report on Friday, November 3rd. Eleven equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $172.36.
In other news, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.
Aetna Inc. (NYSE:AET) traded up $1.51 during mid-day trading on Wednesday, hitting $176.45. 2,194,100 shares of the stock traded hands, compared to its average volume of 2,434,868. The stock has a market cap of $57,047.94, a price-to-earnings ratio of 17.13, a PEG ratio of 1.59 and a beta of 0.61. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc. has a 1 year low of $116.04 and a 1 year high of $184.98.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.07 earnings per share. sell-side analysts forecast that Aetna Inc. will post 9.78 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s dividend payout ratio (DPR) is currently 37.04%.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2017/11/22/norinchukin-bank-the-purchases-13223-shares-of-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.